St. John's Wort Additional Bioactive Components Identified by PharmaPrint
This article was originally published in The Tan Sheet
Executive Summary
PharmaPrint's bioassay system has identified four components of St. John's wort with disease-related bioactivity in addition to the historical standard of hypericin, Senior VP-R&D Michael Tempesta, PhD, told the National Institute of Environmental Health Sciences' conference on medicinal herbs in Raleigh, N.C. Sept. 23.